文献速递心力衰竭与心肌病心律失常

N末端B型利钠肽原与肥厚型心肌病心脏性猝死的关系

N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
PubMed 文献 · Heart · 2020-12-24

该研究前瞻性纳入977例有NT-proBNP结果的无关肥厚型心肌病患者,随访3.0±2.1年。随访期间29例发生心脏性猝死,log NT-proBNP升高与SCD风险增加独立相关(校正HR 22.27,95%CI 10.93-65.63,p<0.001),NT-proBNP预测SCD的C统计量为0.80。将NT-proBNP三分位加入HCM Risk-SCD模型后,预测效率从0.72提升至0.81(p<0.05)。

要点

  • NT-proBNP是HCM患者SCD的独立预测因子。
  • NT-proBNP预测SCD的C统计量为0.80。
  • 加入NT-proBNP三分位可改善HCM Risk-SCD模型预测效率。

核心结论

  • NT-proBNP是肥厚型心肌病患者心脏性猝死的独立预测因子,可能有助于该病的风险分层。

研究设计与样本

  • 前瞻性纳入977例有NT-proBNP结果的无关肥厚型心肌病患者,随访3.0±2.1年。

主要发现

  • 随访期间29例患者发生心脏性猝死。
  • log NT-proBNP水平升高与SCD事件风险增加相关(校正HR 22.27,95%CI 10.93至65.63,p<0.001)。
  • NT-proBNP预测SCD事件的C统计量为0.80(p<0.001)。
  • 联合模型将HCM Risk-SCD模型的预测效率从0.72显著提升至0.81(p<0.05),相对综合判别改善为0.002(p<0.001),净重分类改善为0.67(p<0.001)。
  • log NT-proBNP水平与LGE检测的心肌纤维化(r=0.257,p<0.001)及Masson三色染色检测的心肌纤维化(r=0.198,p<0.05)显著相关。

临床怎么用

  • 在HCM患者中可检测NT-proBNP以辅助SCD风险分层,并考虑将其三分位加入HCM Risk-SCD模型以改善预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Elevated levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) are associated with heart failure-related death in hypertrophic cardiomyopathy (HCM), but the relationship between NT-proBNP level and sudden cardiac death (SCD) in HCM remains undefined. METHODS: The study prospectively enrolled 977 unrelated patients with HCM with available NT-proBNP results who were prospectively enrolled and followed for 3.0±2.1 years. The Harrell's C-statistic under the receiver operating characteristic curve was calculated to evaluate discrimination performance. A combination model was constructed by adding NT-proBNP tertiles to the HCM Risk-SCD model. The correlation between log NT-proBNP level and cardiac fibrosis as measured by late gadolinium enhancement (LGE) or Masson's staining was analysed. RESULTS: During follow-up, 29 patients had SCD. Increased log NT-proBNP levels were associated with an increased risk of SCD events (adjusted HR 22.27, 95% CI 10.93 to 65.63, p<0.001). The C-statistic of NT-proBNP in predicting SCD events was 0.80 (p<0.001). The combined model significantly improved the predictive efficiency of the HCM Risk-SCD model from 0.72 to 0.81 (p<0.05), with a relative integrated discrimination improvement of 0.002 (p<0.001) and net reclassification improvement of 0.67 (p<0.001). Furthermore, log NT-proBNP levels were significantly correlated with cardiac fibrosis as detected either by LGE (r=0.257, p<0.001) or by Masson's trichrome staining in the myocardium (r=0.198, p<0.05). CONCLUSION: NT-proBNP is an independent predictor of SCD in patients with HCM and may help with risk stratification of this disease.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Wu G, Liu J, Wang S, et al. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy. Heart. 2020. PMID: 33361398. doi:10.1136/heartjnl-2020-317701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。